Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions? (Q38105048)

28 August 2017

title

Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions? (English)

1 reference

28 August 2017

0 references

1 reference

Ara Darzi

1 reference

28 August 2017

Thanos Athanasiou

0 references

Leanne Harling

1 reference

28 August 2017

Hutan Ashrafian

1 reference

28 August 2017

publication date

8 May 2013

1 reference

28 August 2017

published in

Metabolic Brain Disease

1 reference

28 August 2017

1 reference

28 August 2017

1 reference

28 August 2017

page(s)

341-353

1 reference

Dementia: a problem for our age.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Midlife adiposity and the future risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Can Alzheimer disease be a form of type 3 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Bariatric surgery - can we afford to do it or deny doing it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Metabolic surgery and gut hormones - a review of bariatric entero-humoral modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Effects of bariatric surgery on cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Metabolic surgery: an evolution through bariatric animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Autobionics: a new paradigm in regenerative medicine and surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Metabolic surgery and cancer: protective effects of bariatric procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Metabolic surgery and obstructive sleep apnoea: the protective effects of bariatric procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

ACAT inhibition and amyloid beta reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Do epigenetic pathways initiate late onset Alzheimer disease (LOAD): towards a new paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Forecasting the global burden of Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

The role of calorie restriction and SIRT1 in prion-mediated neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Genetics of dementia: update and guidelines for the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Benefits of caloric restriction on brain aging and related pathological States: understanding mechanisms to devise novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Insulin and neurodegenerative disease: shared and specific mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Prevention: activity is the best medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Linking lipids to Alzheimer's disease: cholesterol and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Exercise training increases size of hippocampus and improves memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Set-Point Theory and Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Adherence to a Mediterranean diet, cognitive decline, and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Expression of the ghrelin and neurotensin systems is altered in the temporal lobe of Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Role of ghrelin system in neuroprotection and cognitive functions: implications in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

The link between altered cholesterol metabolism and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

GLP-1 amplifies insulin signaling by up-regulation of IRbeta, IRS-1 and Glut4 in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Role of Genes and Environments for Explaining Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Adiposity indices and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

An 18-year follow-up of overweight and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Association between metabolic syndrome and cognitive decline: a systematic review of prospective population-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Neuroprotective properties of GLP-1: theoretical and practical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Islet amyloid and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Increased risk of type 2 diabetes in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Cardiovascular risk factors after bariatric surgery: Do patients gain more than expected from their substantial weight loss?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Statins and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Adult nutrient intake as a risk factor for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

The controversies of statin therapy: weighing the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Nutritional treatment of aged individuals with Alzheimer disease living at home with their spouses: study protocol for a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Anti-Parkinson drugs and orexin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Dietary restriction increases the number of newly generated neural cells, and induces BDNF expression, in the dentate gyrus of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Risk of dementia among persons with diabetes mellitus: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Exercise following bariatric surgery: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Caloric intake and the risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Will caloric restriction and folate protect against AD and PD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Starvation physiology: reviewing the different strategies animals use to survive a common challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Sphingolipids in lipid microdomains and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Islet amyloid polypeptide: identification and chromosomal localization of the human gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Humanin: a novel central regulator of peripheral insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

THE RELATION OE DIABETES MELLITUS TO LESIONS OF THE PANCREAS. HYALINE DEGENERATION OF THE ISLANDS OE LANGERHANS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

A new Alzheimer's disease interventive strategy: GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Dietary restriction started after spinal cord injury improves functional recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Hyperinsulinaemia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

The relationship between diabetes mellitus and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Physical activity, diet, and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Estrogens and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Neuroprotective potential of dietary restriction against kainate-induced excitotoxicity in adult male Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Nutritional status in Parkinson's disease patients undergoing deep brain stimulation surgery: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Obesity exacerbates chemically induced neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Insulin and cognitive function in an elderly population. The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Regulation of brain function by exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

The Alzheimer's disease mitochondrial cascade hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Sphingolipids: critical players in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Brain dopamine and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Insulin increases CSF Abeta42 levels in normal older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Central obesity and increased risk of dementia more than three decades later

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Cholesterol and the biology of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

One year improvements in cardiovascular risk factors: a comparative trial of laparoscopic Roux-en-Y gastric bypass vs. adjustable gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Midlife overweight and obesity increase late-life dementia risk: a population-based twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

Region-Specific Neurotrophin Imbalances in Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-013-9412-4

A clinical approach to early-onset inheritable dementia

21 January 2018

1 reference

12 December 2020

CHEMICAL STUDIES ON ALZHEIMER'S DISEASE

1 reference

12 December 2020

Neuroprotective Role for Galanin in Alzheimer’s Disease

1 reference

12 December 2020

High-dose porcine galanin infusion and effect on intravenous glucose tolerance in humans

1 reference

12 December 2020

Decreased serum betaine concentrations in patients after bariatric surgery

1 reference

12 December 2020

Galanin and vasoactive intestinal polypeptide are colocalised with classical pituitary hormones and show plasticity of expression

1 reference

12 December 2020

The neuroprotective effects of GLP-1: possible treatments for cognitive deficits in individuals with mood disorders

1 reference

12 December 2020

Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity

1 reference

12 December 2020

Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore

1 reference

12 December 2020

GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid

1 reference

12 December 2020

Case-control study of idiopathic Parkinson's disease and dietary vitamin E intake.

1 reference

12 December 2020

Metabolic syndrome and Alzheimer's disease: a link to a vascular hypothesis?

1 reference

12 December 2020

Alzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigenetics

1 reference

12 December 2020

Elevated plasma levels of homocysteine in Parkinson's disease

1 reference

12 December 2020

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease

1 reference

12 December 2020

Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease.

1 reference

12 December 2020

1 reference

12 December 2020

Effect of bariatric surgery on sulphur amino acids and glutamate

1 reference

12 December 2020

Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3.

1 reference

12 December 2020

Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease

1 reference

12 December 2020

Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study

1 reference

12 December 2020

Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults

1 reference

12 December 2020

Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism

1 reference

12 December 2020

Cholesterol depletion with physiological concentrations of a statin decreases the formation of the Alzheimer amyloid Abeta peptide

1 reference

12 December 2020

Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration?

1 reference

12 December 2020

10.1007/S11011-013-9412-4

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1050405088

0 references

1 reference